SYFc67687bee87d4240a6918d10fadc235bRegistry ID: 2023-503686-26-02|RecruitingPhase 1/2
Loading search results
interventional
N/A
1 country
1
To evaluate whether baseline pulmonary FAPI uptake on PET/CT differs between subsequent responders and non-responders to a clinically indicated modification of anti-inflammatory therapy in patients with fibrotic ILD, and to estimate the magnitude and uncertainty of this difference.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
Not reported
Date not reportedClick on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
July 24, 2024
Actual (reported)The difference in baseline wlTL-FAPI between participants classified as responders and non-responders at six months
The correlation between baseline wlTL-FAPI and the continuous absolute change in FVC% predicted from baseline to six months
The prognostic classification performance of baseline wlTL-FAPI, assessed using the area under the receiver operating characteristic curve and estimates of sensitivity, specificity, positive predictive value and negative predictive value, with 95% confidence intervals
Data-derived candidate wlTL-FAPI threshold(s) and their corresponding sensitivity, specificity, positive predictive value and negative predictive value
Between-group differences and associations for qualitative visual assessment, SUVmax, SUVmean, metabolic active volume and whole-lung metabolic active volume
The association between baseline wlTL-FAPI and the extent of fibrotic ILD and degree of reticulation on baseline HRCT
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
St Antonius Hospital
Nieuwegein, 3435 CM, Netherlands
Andor van den Hoven
First Submitted
July 24, 2024
Download the complete CTIS (EMA) record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: European Medicines Agency (EMA), Clinical Trials Information System (CTIS). Original record and public documents are available on CTIS.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved:
Contact the study team to confirm eligibility.